The benefits of peritoneal dialysis (PD) solution with low-glucose degradation product in residual renal function and dialysis adequacy in PD patients: A meta-analysis.
Investigación Clínica · 2022
DOI: 10.54817/ic.v63n3a07 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Investigación Clínica, 2022. Verfasst von Sheng Chen und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The peritoneal effects of low-glucose degradation product (GDP)-containing peritoneal dialysis (PD) solutions have been extensively described. To systematically evaluate the efficacy and safety of low GDP solution for PD patients, specifically the effect on residual renal function (RRF) and dialysis adequacy, we conducted a meta-analysis of the published randomized controlled trials (RCTs). Different databases were searched for RCTs that compared low GDP-PD solutions with conventional PD solutions in the treatment of PD patients with continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). The outcomes of RCTs should include RRF and may include small solute clear-ance, peritoneal transport status, nutritional status, and all-cause mortality. Seven studies (632 patients) were included. Compared with the conventional solution, low-GDP solution preserved RRF in PD patients over time (MD 0.66 mL/min, 95% CI 0.34 to 0.99; p
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Chen, S., Jia, J., Guo, H., & Zhu, N. (2022). The benefits of peritoneal dialysis (PD) solution with low-glucose degradation product in residual renal function and dialysis adequacy in PD patients: A meta-analysis. Investigación Clínica. https://doi.org/10.54817/ic.v63n3a07
Vancouver
Chen S, Jia J, Guo H, Zhu N. The benefits of peritoneal dialysis (PD) solution with low-glucose degradation product in residual renal function and dialysis adequacy in PD patients: A meta-analysis. Investigación Clínica. 2022. doi:10.54817/ic.v63n3a07
BibTeX
@article{Chen2022,
author = {Chen, Sheng and Jia, Jieshuang and Guo, Huimin and Zhu, Nan},
title = {The benefits of peritoneal dialysis (PD) solution with low-glucose degradation product in residual renal function and dialysis adequacy in PD patients: A meta-analysis},
journal = {Investigación Clínica},
year = {2022},
doi = {10.54817/ic.v63n3a07}
}
EUVIMED